Timing of aspirin administration as a determinant of survival of patients with acute myocardial infarction treated with thrombolysis

American Journal of Cardiology

Volumn 89, Issue 4, 2002, Pages 381-385

  Freimark, Dov ^a   Matetzky, Shlomo ^a   Leor, Jonathan ^a,b   Boyko, Valentina ^a   Barbash, Israel M ^a   Behar, Solomon ^a   Hod, Hanoch ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b SHEBA MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; FIBRINOLYTIC AGENT;

ACUTE HEART INFARCTION; ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD CLOT LYSIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DILATATION; DOSE TIME EFFECT RELATION; FEMALE; FIBRINOLYTIC THERAPY; HEART MUSCLE ISCHEMIA; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; REVASCULARIZATION; STATISTICAL ANALYSIS; SURVIVAL RATE; SYMPTOMATOLOGY; TREATMENT OUTCOME;

AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; RANDOMIZED CONTROLLED TRIALS; SURVIVAL ANALYSIS; THROMBOLYTIC THERAPY;

EID: 0037083218     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(01)02256-1     Document Type: Article

References (13)

1. Improved survival of patients with acute myocardial infarction with significant left ventricular dysfunction undergoing invasive coronary procedures
2. Previous aspirin use may attenuate the severity of the manifestation of acute ischemic syndromes
3. Influence of previous aspirin treatment and smoking on the electrocardiographic manifestations of injury in acute myocardial infarction
4. Infarct size is reduced and the frequency of non-Q-wave myocardial infarctions is increased in patients using aspirin at the onset of symptoms
5. Randomised trial of intravenous streptokinase oral aspirin both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2
6. Marked platelet activation in vivo after intravenous streptokinase in patients with acute myocardial infarction
7. Aspirin
8. Early thrombolytic treatment in acute myocardial infarction: Reappraisal of the golden hour
9. Selection of reperfusion therapy for individual patients with evolving myocardial infarction
10. Does aspirin consumption affect the presentation or severity of acute myocardial infarction?
11. Improving the quality of care for medicare patients with acute myocardial infarction: Results from the Cooperative Cardiovascular Project
12. Patterns of aspirin use in middle-aged adults: The Atherosclerosis Risk in Communities (ARIC) Study
13. A British Cardiac Society survey of the potential for the secondary prevention of coronary disease: ASPIRE (Action on Secondary Prevention through Intervention to Reduce Events)